Siwiec, J.; Kuźnik-Trocha, K.; Winsz-Szczotka, K.; Komosińska-Vassev, K.; Siwiec, A.; Olczyk, K.
The Impact of 24-Month Etanercept Therapy on Changes in Adiponectin, Leptin and Tenascin C Levels in the Blood of Children with Juvenile Idiopathic Arthritis. Pharmaceuticals 2025, 18, 1423.
https://doi.org/10.3390/ph18091423
AMA Style
Siwiec J, Kuźnik-Trocha K, Winsz-Szczotka K, Komosińska-Vassev K, Siwiec A, Olczyk K.
The Impact of 24-Month Etanercept Therapy on Changes in Adiponectin, Leptin and Tenascin C Levels in the Blood of Children with Juvenile Idiopathic Arthritis. Pharmaceuticals. 2025; 18(9):1423.
https://doi.org/10.3390/ph18091423
Chicago/Turabian Style
Siwiec, Jan, Kornelia Kuźnik-Trocha, Katarzyna Winsz-Szczotka, Katarzyna Komosińska-Vassev, Andrzej Siwiec, and Krystyna Olczyk.
2025. "The Impact of 24-Month Etanercept Therapy on Changes in Adiponectin, Leptin and Tenascin C Levels in the Blood of Children with Juvenile Idiopathic Arthritis" Pharmaceuticals 18, no. 9: 1423.
https://doi.org/10.3390/ph18091423
APA Style
Siwiec, J., Kuźnik-Trocha, K., Winsz-Szczotka, K., Komosińska-Vassev, K., Siwiec, A., & Olczyk, K.
(2025). The Impact of 24-Month Etanercept Therapy on Changes in Adiponectin, Leptin and Tenascin C Levels in the Blood of Children with Juvenile Idiopathic Arthritis. Pharmaceuticals, 18(9), 1423.
https://doi.org/10.3390/ph18091423
